Myriad Genetics | MYGN - Zinsaufwendungen Für Schuld

Aktienkurs
4.59
Täglich Wechseln
-0.16 -3.37%
Monatlich
4.79%
Jährlich
-54.15%
Q1 Prognose
4.52




Zinsaufwendungen Für Schuld Veränderung Datum
Agilent USD 25M 2M 2025-12
Becton, Dickinson and Co. USD 153M 2M 2025-12
Bio-Rad Laboratories USD 12.3M 100K 2025-09
Bruker USD 20M 4.3M 2025-09
Danaher USD 55M 12M 2025-12
Exact Sciences USD 9.79M 46K 2025-09
Hologic USD 27.6M 1000K 2025-12
Illumina USD 25M 0 2025-09
J&J USD 18M 290M 2025-09
Mettler Toledo International USD 17.39M 307K 2025-12
Myriad Genetics USD 4.4M 600K 2025-12
OraSure Technologies 1.67M 1.13M 2025-12
Pacific Biosciences Of California USD 1.74M 1000 2025-12
Quest Diagnostics USD 69M 2M 2025-09
Quidel USD 5.68B 5.63B 2025-09
Repligen USD 5.5M 81K 2025-12
Revvity USD 23.51M 742K 2025-12
Standard Biotools USD 5K 5K 2025-12
Thermo Fisher Scientific USD 365M 18M 2025-12
Veracyte USD 2K 1000 2023-12
Waters USD 8.62M 18.02M 2025-12